한글목차

근시 및 노안 치료 시장은 2022-2027년간 79억 4,629만 달러 확대되고, 예측 기간중 연평균 복합 성장률(CAGR)은 8.09%를 나타낼 것으로 예측됩니다.

근시 및 노안 치료 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 시장 성장 촉진요인 및 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 성장요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 근시와 노안 유병률 증가, 시력 케어에 관한 의식 고양, 고령화 사회 시력 교정 수요 증가에 힘입어 시장 성장이 가속화되고 있습니다.

본 조사에서는 향후 몇 년간 근시 및 노안 치료 시장 성장을 가속하는 주요인 중 하나로서 근시 및 노안 치료 최근 동향을 들고 있습니다. 또한 저비용 안과 수술을 위한 의료관광 증가나 다초점 안내 렌즈의 출현은 시장의 큰 수요로 연결됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2022년)
• 시장 전망(2022-2027년)

제4장 시장 규모 실적

• 근시 및 노안 치료 세계 시장(2017-2021년)
• 유형 부문 분석(2017-2021년)
• 제품 부문 분석(2017-2021년)
• 지역별 부문 분석(2017-2021년)
• 국가별 부문 분석(2017-2021년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 근시 치료 : 시장 규모와 예측(2022-2027년)
• 노안 치료 : 시장 규모와 예측(2022-2027년)
• 시장 기회 : 유형별

제7장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 렌즈와 유리 : 시장 규모와 예측(2022-2027년)
• 외과 수술 : 시장 규모와 예측(2022-2027년)
• 약제 : 시장 규모와 예측(2022-2027년)
• 시장 기회 : 제품별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 아시아 : 시장 규모와 예측(2022-2027년)
• 북미 : 시장 규모와 예측(2022-2027년)
• 유럽 : 시장 규모와 예측(2022-2027년)
• 세계 기타 지역 : 시장 규모와 예측(2022-2027년)
• 미국 : 시장 규모와 예측(2022-2027년)
• 중국 : 시장 규모와 예측(2022-2027년)
• 독일 : 시장 규모와 예측(2022-2027년)
• 캐나다 : 시장 규모와 예측(2022-2027년)
• 일본 : 시장 규모와 예측(2022-2027년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• AbbVie Inc.
• Alcon Inc.
• Bausch Health Companies Inc.
• BVI Holdings Ltd.
• Carl Zeiss AG
• EssilorLuxottica
• Johnson and Johnson
• Metall Zug AG
• NIDEK Co. Ltd.
• Ophtec BV
• Orasis Pharmaceuticals Inc.
• Regeneron Pharmaceuticals Inc.
• Sydnexis Inc.
• Topcon Corp.
• Ziemer Ophthalmic Systems AG

제13장 부록

영문목차

The myopia and presbyopia treatment market is forecasted to grow by USD 7946.29 mn during 2022-2027, accelerating at a CAGR of 8.09% during the forecast period. The report on the myopia and presbyopia treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of myopia and presbyopia, rising awareness regarding vision care, and growing demand for vision correction among the aging population.

Technavio's myopia and presbyopia treatment market is segmented as below:

By Type

• Myopia treatment
• Presbyopia treatment

By Product

• Lenses and glass
• Surgery
• Drug

By Geographical Landscape

• Asia
• North America
• Europe
• Rest of World (ROW)

This study identifies the recent developments in myopia and presbyopia treatment as one of the prime reasons driving the myopia and presbyopia treatment market growth during the next few years. Also, increasing medical tourism for low-cost ophthalmology surgeries and emergence of multifocal intraocular lenses will lead to sizable demand in the market.

The report on the myopia and presbyopia treatment market covers the following areas:

• Myopia and presbyopia treatment market sizing
• Myopia and presbyopia treatment market forecast
• Myopia and presbyopia treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading myopia and presbyopia treatment market vendors that include AbbVie Inc., Alcon Inc., Arctic Vision, Bausch Health Companies Inc., BVI Holdings Ltd., Carl Zeiss AG, ENTOD INTERNATIONAL, EssilorLuxottica, F. Hoffmann La Roche Ltd., Johnson and Johnson, Metall Zug AG, NIDEK Co. Ltd., Ophtec BV, Orasis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanjeevan School For Perfect Eyesight, Sydnexis Inc., The Cooper Companies Inc., Topcon Corp., Vision Care Group, Visus Therapeutics Inc., Ziemer Ophthalmic Systems AG, and Evotec SE. Also, the myopia and presbyopia treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global myopia and presbyopia treatment market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global myopia and presbyopia treatment market 2017 - 2021 ($ million)
• 4.2 Type Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• 4.3 Product Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Myopia treatment - Market size and forecast 2022-2027
• Exhibit 34: Chart on Myopia treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Myopia treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Myopia treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Myopia treatment - Year-over-year growth 2022-2027 (%)
• 6.4 Presbyopia treatment - Market size and forecast 2022-2027
• Exhibit 38: Chart on Presbyopia treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Presbyopia treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Presbyopia treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Presbyopia treatment - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 44: Chart on Product - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Product - Market share 2022-2027 (%)
• 7.2 Comparison by Product
• Exhibit 46: Chart on Comparison by Product
• Exhibit 47: Data Table on Comparison by Product
• 7.3 Lenses and glass - Market size and forecast 2022-2027
• Exhibit 48: Chart on Lenses and glass - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Lenses and glass - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Lenses and glass - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Lenses and glass - Year-over-year growth 2022-2027 (%)
• 7.4 Surgery - Market size and forecast 2022-2027
• Exhibit 52: Chart on Surgery - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Surgery - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Surgery - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Surgery - Year-over-year growth 2022-2027 (%)
• 7.5 Drug - Market size and forecast 2022-2027
• Exhibit 56: Chart on Drug - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Drug - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Drug - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Drug - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ million)
• Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 Asia - Market size and forecast 2022-2027
• Exhibit 67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.4 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.5 Europe - Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 China - Market size and forecast 2022-2027
• Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 Canada - Market size and forecast 2022-2027
• Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 111: AbbVie Inc. - Overview
• Exhibit 112: AbbVie Inc. - Product / Service
• Exhibit 113: AbbVie Inc. - Key news
• Exhibit 114: AbbVie Inc. - Key offerings
• 12.4 Alcon Inc.
• Exhibit 115: Alcon Inc. - Overview
• Exhibit 116: Alcon Inc. - Business segments
• Exhibit 117: Alcon Inc. - Key offerings
• Exhibit 118: Alcon Inc. - Segment focus
• 12.5 Bausch Health Companies Inc.
• Exhibit 119: Bausch Health Companies Inc. - Overview
• Exhibit 120: Bausch Health Companies Inc. - Business segments
• Exhibit 121: Bausch Health Companies Inc. - Key news
• Exhibit 122: Bausch Health Companies Inc. - Key offerings
• Exhibit 123: Bausch Health Companies Inc. - Segment focus
• 12.6 BVI Holdings Ltd.
• Exhibit 124: BVI Holdings Ltd. - Overview
• Exhibit 125: BVI Holdings Ltd. - Product / Service
• Exhibit 126: BVI Holdings Ltd. - Key offerings
• 12.7 Carl Zeiss AG
• Exhibit 127: Carl Zeiss AG - Overview
• Exhibit 128: Carl Zeiss AG - Business segments
• Exhibit 129: Carl Zeiss AG - Key offerings
• Exhibit 130: Carl Zeiss AG - Segment focus
• 12.8 EssilorLuxottica
• Exhibit 131: EssilorLuxottica - Overview
• Exhibit 132: EssilorLuxottica - Business segments
• Exhibit 133: EssilorLuxottica - Key offerings
• Exhibit 134: EssilorLuxottica - Segment focus
• 12.9 Johnson and Johnson
• Exhibit 135: Johnson and Johnson - Overview
• Exhibit 136: Johnson and Johnson - Business segments
• Exhibit 137: Johnson and Johnson - Key news
• Exhibit 138: Johnson and Johnson - Key offerings
• Exhibit 139: Johnson and Johnson - Segment focus
• 12.10 Metall Zug AG
• Exhibit 140: Metall Zug AG - Overview
• Exhibit 141: Metall Zug AG - Business segments
• Exhibit 142: Metall Zug AG - Key offerings
• Exhibit 143: Metall Zug AG - Segment focus
• 12.11 NIDEK Co. Ltd.
• Exhibit 144: NIDEK Co. Ltd. - Overview
• Exhibit 145: NIDEK Co. Ltd. - Business segments
• Exhibit 146: NIDEK Co. Ltd. - Key offerings
• Exhibit 147: NIDEK Co. Ltd. - Segment focus
• 12.12 Ophtec BV
• Exhibit 148: Ophtec BV - Overview
• Exhibit 149: Ophtec BV - Product / Service
• Exhibit 150: Ophtec BV - Key offerings
• 12.13 Orasis Pharmaceuticals Inc.
• Exhibit 151: Orasis Pharmaceuticals Inc. - Overview
• Exhibit 152: Orasis Pharmaceuticals Inc. - Product / Service
• Exhibit 153: Orasis Pharmaceuticals Inc. - Key offerings
• 12.14 Regeneron Pharmaceuticals Inc.
• Exhibit 154: Regeneron Pharmaceuticals Inc. - Overview
• Exhibit 155: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibit 156: Regeneron Pharmaceuticals Inc. - Key offerings
• 12.15 Sydnexis Inc.
• Exhibit 157: Sydnexis Inc. - Overview
• Exhibit 158: Sydnexis Inc. - Product / Service
• Exhibit 159: Sydnexis Inc. - Key offerings
• 12.16 Topcon Corp.
• Exhibit 160: Topcon Corp. - Overview
• Exhibit 161: Topcon Corp. - Business segments
• Exhibit 162: Topcon Corp. - Key news
• Exhibit 163: Topcon Corp. - Key offerings
• Exhibit 164: Topcon Corp. - Segment focus
• 12.17 Ziemer Ophthalmic Systems AG
• Exhibit 165: Ziemer Ophthalmic Systems AG - Overview
• Exhibit 166: Ziemer Ophthalmic Systems AG - Product / Service
• Exhibit 167: Ziemer Ophthalmic Systems AG - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 168: Inclusions checklist
• Exhibit 169: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 170: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 171: Research methodology
• Exhibit 172: Validation techniques employed for market sizing
• Exhibit 173: Information sources
• 13.5 List of abbreviations
• Exhibit 174: List of abbreviations